Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 23 | $651,220 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
02 Feb 2023 13:02 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 31 Jan 2023 | Sale | 248 | 10.12 | 2,510 | D |
02 Nov 2022 16:31 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 31 Oct 2022 | Sale | 258 | 11.85 | 3,057 | D |
02 Feb 2023 13:04 | URGN | UroGen Pharma Ltd. | SMITH JASON DREW | General Counsel | 31 Jan 2023 | Sale | 409 | 10.12 | 4,139 | D |
02 Feb 2024 19:12 | URGN | UroGen Pharma Ltd. | SMITH JASON DREW | General Counsel | 31 Jan 2024 | Sale | 417 | 15.74 | 6,564 | D |
05 Feb 2024 21:16 | URGN | UroGen Pharma Ltd. | SMITH JASON DREW | General Counsel | 01 Feb 2024 | Sale A | 417 | 15.78 | 6,580 | D |
02 Feb 2023 13:02 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 31 Jan 2023 | Sale | 661 | 10.12 | 6,689 | D |
02 Feb 2023 13:02 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 31 Jan 2023 | Sale | 991 | 10.12 | 10,029 | D |
12 Sep 2024 13:54 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 09 Sep 2024 | Sale | 859 | 13.08 | 11,236 | D |
02 Feb 2024 19:07 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 31 Jan 2024 | Sale | 758 | 15.74 | 11,931 | D |
05 Feb 2024 21:15 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 01 Feb 2024 | Sale A | 758 | 15.78 | 11,961 | D |
02 Feb 2023 13:04 | URGN | UroGen Pharma Ltd. | SMITH JASON DREW | General Counsel | 31 Jan 2023 | Sale | 1,227 | 10.12 | 12,417 | D |
02 Feb 2024 19:07 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 31 Jan 2024 | Sale | 1,137 | 15.74 | 17,896 | D |
05 Feb 2024 21:15 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 01 Feb 2024 | Sale A | 1,137 | 15.78 | 17,942 | D |
02 Feb 2024 19:12 | URGN | UroGen Pharma Ltd. | SMITH JASON DREW | General Counsel | 31 Jan 2024 | Sale | 1,248 | 15.74 | 19,644 | D |
05 Feb 2024 21:16 | URGN | UroGen Pharma Ltd. | SMITH JASON DREW | General Counsel | 01 Feb 2024 | Sale A | 1,248 | 15.78 | 19,693 | D |
12 Sep 2024 13:51 | URGN | UroGen Pharma Ltd. | SMITH JASON DREW | General Counsel | 09 Sep 2024 | Sale | 1,521 | 13.08 | 19,895 | D |
02 Feb 2024 19:07 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 31 Jan 2024 | Sale | 1,894 | 15.74 | 29,812 | D |
05 Feb 2024 21:15 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 01 Feb 2024 | Sale A | 1,894 | 15.78 | 29,887 | D |
02 Feb 2024 19:12 | URGN | UroGen Pharma Ltd. | SMITH JASON DREW | General Counsel | 31 Jan 2024 | Sale | 3,328 | 15.74 | 52,383 | D |
05 Feb 2024 21:16 | URGN | UroGen Pharma Ltd. | SMITH JASON DREW | General Counsel | 01 Feb 2024 | Sale A | 3,328 | 15.78 | 52,516 | D |
11 Jun 2024 13:15 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 10 Jun 2024 | Sale | 5,153 | 13.08 | 67,401 | D |
05 Sep 2023 16:28 | URGN | UroGen Pharma Ltd. | SMITH JASON DREW | General Counsel | 31 Aug 2023 | Sale | 3,800 | 18.01 | 68,438 | D |
20 Mar 2024 16:38 | URGN | UroGen Pharma Ltd. | SCHOENBERG MARK | Chief Medical Officer | 18 Mar 2024 | Sale | 12,000 | 14.05 | 168,600 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)